Hypertrabeculation; a phenotype with Heterogeneous etiology
- PMID: 34265334
- DOI: 10.1016/j.pcad.2021.07.007
Hypertrabeculation; a phenotype with Heterogeneous etiology
Abstract
Left ventricular hypertrabeculation (LVHT) is a phenotype with multiple etiologies and variable clinical presentation and significance. It is characterized by a 2-layer myocardium with an enlarged trabecular layer and a thinner compacted layer. The prevalence has been increasing due to advances in cardiac imaging. Initial attention was focused on the congenital noncompaction syndrome, and the presence of LVHT was always attributed to this etiology. However, due to the lack of consensus diagnostic criteria, LVHT has now been reported in a broad spectrum of cardiomyopathies, congenital heart diseases, monogenetic disorders, neuromuscular diseases, and even healthy individuals. LVHT is often associated with systolic dysfunction, arrhythmias, and thromboembolic events. Given the etiologic heterogeneity, the prognosis and outcomes are primarily determined by comorbidities, and treatment is dictated by known guidelines. We present hypertrabeculation (HT) as a phenotype and discuss the varied landscape in the classification, etiology, diagnosis, and management of the condition.
Keywords: Congenital noncompaction syndrome; Echocardiography; Left ventricular hypertrabeculation; Magnetic resonance imaging.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
Bridging the gap between hypertrabeculation phenotype, noncompaction phenotype and left ventricular noncompaction cardiomyopathy.J Cardiovasc Med (Hagerstown). 2020 Mar;21(3):192-199. doi: 10.2459/JCM.0000000000000924. J Cardiovasc Med (Hagerstown). 2020. PMID: 31895132 Review.
-
Understanding left ventricular hypertrabeculation/noncompaction: pathomorphologic findings and prognostic impact of neuromuscular comorbidities.Expert Rev Cardiovasc Ther. 2019 Feb;17(2):95-109. doi: 10.1080/14779072.2019.1561280. Epub 2018 Dec 31. Expert Rev Cardiovasc Ther. 2019. PMID: 30570401 Review.
-
Regression of left ventricular hypertrabeculation is associated with improvement in systolic function and favorable prognosis in adult patients with non-ischemic cardiomyopathy.J Cardiol. 2016 Nov;68(5):431-438. doi: 10.1016/j.jjcc.2015.11.008. Epub 2015 Dec 28. J Cardiol. 2016. PMID: 26740463
-
Interobserver Agreement of the Echocardiographic Diagnosis of LV Hypertrabeculation/Noncompaction.JACC Cardiovasc Imaging. 2015 Nov;8(11):1252-7. doi: 10.1016/j.jcmg.2015.04.026. JACC Cardiovasc Imaging. 2015. PMID: 26563854
-
Left ventricular hypertrabeculation/noncompaction in a patient with peripartum cardiomyopathy.Int J Cardiol. 2010 Mar 4;139(2):e18-20. doi: 10.1016/j.ijcard.2008.08.025. Epub 2008 Sep 14. Int J Cardiol. 2010. PMID: 18793811
Cited by
-
Contrast Echocardiography in Heart Failure: Update 2023.Curr Heart Fail Rep. 2024 Apr;21(2):63-72. doi: 10.1007/s11897-024-00647-z. Epub 2024 Feb 2. Curr Heart Fail Rep. 2024. PMID: 38305851 Review.
-
Highlights of right ventricular characteristics of left ventricular noncompaction using 3D echocardiography.Int J Cardiol Heart Vasc. 2023 Nov 15;49:101289. doi: 10.1016/j.ijcha.2023.101289. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 38035261 Free PMC article.
-
Established and emerging roles for ultrasound enhancing agents (contrast echocardiography).Clin Cardiol. 2022 Nov;45(11):1114-1122. doi: 10.1002/clc.23924. Epub 2022 Oct 2. Clin Cardiol. 2022. PMID: 36183366 Free PMC article. Review.
-
Left Ventricular Non-Compaction Cardiomyopathy-Still More Questions than Answers.J Clin Med. 2022 Jul 16;11(14):4135. doi: 10.3390/jcm11144135. J Clin Med. 2022. PMID: 35887898 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
